At 6.0% CAGR, the Middle East & Africa Anatomic Pathology Market is Projected to be Worth US$ 1,183.18 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the Middle East & Africa anatomic pathology market was valued at US$ 740.39 in 2023 and is expected to reach US$ 1,183.18 million by 2031, registering a CAGR of 6.0% from 2023 to 2031. Integration of artificial intelligence and machine learning and growing focus on personalized medicines are among the critical factors attributed to the Middle East & Africa anatomic pathology market expansion.

Digital pathology, a growing subfield within anatomical pathology, uses digital technologies to streamline data collection and management. It helps reduce risks to specimen samples and has the potential to accelerate enrolment in clinical trials. Additionally, digital pathology can reduce sample-to-result turnaround time and streamline the central pathology review process, further offering opportunities to increase trial efficiency.

Introducing upgraded technologies, machine learning (ML) and artificial intelligence (AI) are integrated with digital pathology for proper analysis and management of data. Several anatomic pathology laboratories are becoming increasingly aware of the benefits of digitization and AI in practice. Moreover, recent technological advancements and regulatory approvals are encouraging the digitalization of laboratory operations to improve the speed and accuracy of processes. With AI and ML, pathologists will have an augmented ability to improve diagnostic accuracy, efficiency, and consistency.

In November 2023, Dedalus Group and Ibex Medical Analytics launched a fully integrated End-to-End AI-powered Digital Pathology Solution for cancer diagnostics. It enables complete digitization of anatomic pathology labs with a next-generation Anatomic Pathology Information System (AIS) and DP solution, harnessing the power of data and AI for assisted case prioritization, advanced image analysis, and reproducible diagnoses. The rising focus on integrating AI technology for anatomical pathology processes due to its benefits is expected to act as a trend and is expected to fuel the growth of the market in the forecast period.

On the contrary, lack of skilled professionals hampers the growth of Middle East & Africa anatomic pathology market.

Based on product and services, the Middle East & Africa anatomic pathology market is segmented into services, instruments, and consumables. The instruments segment held 45.4% share of the Middle East & Africa anatomic pathology market in 2023, amassing US$ 336.42 million. It is projected to garner US$ 501.34 million by 2031 to expand at 5.1% CAGR during 2023–2031. The services segment is further sub segmented into histopathology and cytopathology. The instruments segment is further sub segmented into microtomes and cryostat, automatic stainer's, tissue processors, and others.

By application, the Middle East & Africa anatomic pathology market is segmented into disease diagnosis, drug discovery and development and others. The disease diagnosis segment held 67.3% share of the Middle East & Africa anatomic pathology market in 2023, amassing US$ 498.08 million. It is projected to garner US$ 826.82 million by 2031 to expand at 6.5% CAGR during 2023–2031.

By end user, the Middle East & Africa anatomic pathology market is segmented into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held 36.0% share of the Middle East & Africa anatomic pathology market in 2023, amassing US$ 266.38 million. It is projected to garner US$ 434.15 million by 2031 to expand at 6.3% CAGR during 2023–2031.

Based on country, the Middle East & Africa anatomic pathology market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa held 38.6% share of Middle East & Africa anatomic pathology market in 2023, amassing US$ 285.45 million. It is projected to garner US$ 481.66 million by 2031 to expand at 6.8% CAGR during 2023–2031.

Key players operating in the Middle East & Africa anatomic pathology market are F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com